Cookie Policy

PhaseBio Pharmaceuticals, Inc.

Filing Date
October 24, 2022
Case Number
22-10995
District
District of Delaware

$10M-$50M

$10M-$50M

Docket
Docket
Pacer Link $$Claims Agent

On October 24, 2022 PhaseBio Pharmaceuticals, Inc. filed for chapter 11 protection in the District of Delaware (Case No. 22-10995). The Debtor reports assets of $10M-$50M and liabilities of $10M-$50M. The Petition states funds will be available to Unsecured Creditors.

Per Claims Agent:
Debtor Represented by:

Daniel J. DeFranceschi

Richards, Layton & Finger


Company Information:
Address:

1 Great Valley Parkway

Suite 30

Malvern, PA 19355

Map to Debtor
Website:
https://www.phasebio.com
Description:
PhaseBio is focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary indications.
Industry:

Share this Filing

Petition image
View
Petition
National corporate Chapter 11 filings, including free copies of petitions
New Email Subscription Options*
Choose:
-Real Time Filing Alerts
-Real Time Filing Alerts- Filter by Liabilities *
-Daily Filings Summary*
-Daily Bankruptcy and Restructuring News*
Follow Us
Linkedin
Twitter
Email
Reddit
Recent Filings
65 Phipps Ave, LLC
Eastern District of New York
BJL Express, LLC
Northern District of Georgia
AP Orangevale, LLC
District of Delaware
N.F. International Inc
Northern District of Georgia
SQUARED UP HOSPITALITY, INC.
District of Arizona
View More Filings
Click to View Sortable List of Filings
Press Release:
Issues with Display? Click Here
Note: we do not represent the Debtor in this case and this information is obtained from automated sources and may not be 100% accurate.
Petition image
Petition
Computer image
New! Dockets